Booz Allen to pay $377.5M in improper billing case
By 
Jeff Dale2023-07-24T18:51:00
Consulting firm Booz Allen Hamilton Holding Corp. agreed to pay approximately $377.5 million as part of a settlement with the Department of Justice (DOJ) regarding alleged False Claims Act violations stemming from improper billing of commercial and international costs in government contracts.
Booz Allen allegedly charged the government in contracts where the costs did not have a direct nexus to the contract’s objective, resulting in use of taxpayer funds for nongovernment-related work, the DOJ said in a press release Friday.
The settlement total is one of the largest in procurement fraud settlements history, said U.S. Attorney Matthew Graves in the release. It includes nearly $210 million in restitution, according to the settlement agreement.
Related articles
-
News BriefLincare to pay $29M over false claims for improperly billing Medicare
Lincare Holdings, a provider of oxygen equipment and subsidiary of Linde, agreed to pay $29 million to resolve allegations it violated the False Claims Act by fraudulently overbilling Medicare.
-
News BriefMartin’s Point Health Care to pay $22.5M to settle false claims case
Martin’s Point Health Care will pay nearly $22.5 million to settle allegations it violated the False Claims Act by knowingly submitting inaccurate diagnosis codes for Medicare enrollees to increase reimbursements.
-
News BriefNextGen Healthcare to pay $31M in false claims case
Electronic health record technology vendor NextGen Healthcare agreed to pay $31 million as part of a settlement announced by the Department of Justice for allegedly misrepresenting the capabilities of its software.
More from Regulatory Enforcement
-
News BriefCFPB ends probe into Meta’s financial advertising practices
Meta says it is no longer under investigation by the U.S. Consumer Financial Protection Bureau (CFPB), the latest instance of the agency scaling back enforcement under President Donald Trump.
-
News BriefTexas sues Johnson & Johnson, Kenvue over alleged misleading marketing of Tylenol
Texas Attorney General Ken Paxton sued two pharmaceutical companies for ”deceptively marketing Tylenol to pregnant mothers” despite risks linked to autism. The filing came two days before HHS Secretary Robert F. Kennedy Jr. appeared to walk back the claims.
-
News BriefCFPB scraps bad-actor registry, citing cost-benefit issues
The Consumer Financial Protection Bureau shut down a registry of non-bank financial firms that broke consumer laws. The agency cites the costs being ”not justified by the speculative and unquantified benefits to consumers.”